Retroperitoneal relapse in an older patient with multiple myeloma during pomalidomide and dexamethasone treatment

Geriatr Gerontol Int. 2018 Jun;18(6):977-979. doi: 10.1111/ggi.13298.

Authors

Naoki Watanabe¹, Hideaki Kitahara¹, Noriaki Iwao¹, Yaunori Ohta², Michiaki Koike¹, Norio Komatsu³

Affiliations

¹ Department of Hematology, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
² Department of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
³ Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

PMID: 29924492
DOI: 10.1111/ggi.13298

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents, Hormonal / therapeutic use*
Dexamethasone / therapeutic use*
Female
Humans
Immunologic Factors / therapeutic use*
Multiple Myeloma / diagnosis*
Multiple Myeloma / therapy*
Recurrence
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Antineoplastic Agents, Hormonal
Immunologic Factors
Thalidomide
Dexamethasone
pomalidomide